Thus, taking advantage of a zebrafish model of pharmacological modulation of visual behaviour, we were able to further assess the neuroprotective efficacy of our nanocarrier, paving the way for the development of neurotrophin-based therapeutical strategies against CSE-induced retinal degeneration. The gene discussed is BDNF; the disease is retinal degeneration.